Vogloyd 3D 2mg/500mg/0.3mg Tablet SR
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vogloyd 3D 2mg/500mg/0.3mg Tablet SR
TriLyte-D 2mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by managing blood glucose levels. TriLyte-D should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially causing kidney damage, vision loss, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. TriLyte-D is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Uses of Vogloyd 3D 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogloyd 3D 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Vogloyd 3D 2mg/500mg/0.3mg Extended-Release Tablets on an empty stomach.
Common Side effects of Vogloyd 3D 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vogloyd 3D 2mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogloyd 3D 2mg/500mg/0.3mg Extended-Release Tablets should be taken on an empty stomach.
How Vogloyd 3D 2mg/500mg/0.3mg Tablet SR works:
Vogloyd 3D extended-release tablets (2mg/500mg/0.3mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Vogloyd 3D 2mg/500mg/0.3mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Vogloyd 3D 2mg/500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vogloyd 3D 2mg/500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Scant human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Vogloyd 3D 2mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice is recommended. The use of Vogloyd 3D 2mg/500mg/0.3mg Tablet SR is contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Vogloyd 3D 2mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, Vogloyd 3D 2mg/500mg/0.3mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Vogloyd 3D 2mg/500mg/0.3mg Tablet SR :
Should you forget a Vogloyd 3D 2mg/500mg/0.3mg Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogloyd 3D 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently